CytoDyn Inc.

CytoDyn Inc.
Stock Exchange Other OTC
EPS
$0.21
Market Cap
$167.64 M
Shares Outstanding
364.43 M
Public Float
254.81 M

Profile

Address
1111 Main Street
Vancouver Washington 98660
United States
Employees -
Website http://www.cytodyn.com
Updated 07/08/2019
CytoDyn, Inc. is a clinical-stage biotechnology company, which engages in the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of human immunodeficiency virus infection. Its product pipeline includes PRO 140, CytoFeline, and Cytolin. The company was founded by Allen D.

Financials

View All
Created with Highcharts 5.0.14CytoDyn Inc.Net Income. Fiscal year is June-May. All values USD Thousands.12 43112 43125 08825 08825 70325 70325 76325 76350 14950 14920142015201620172018010k20k30k40k50k60k

Anthony D. Caracciolo
Non-Executive Chairman
Nader Z. Pourhassan
President, Chief Executive Officer & Director